Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 144,247,584
  • Shares Outstanding, K 536,376
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • 60-Month Beta 0.58
  • Price/Sales 5.00
  • Price/Cash Flow 10.08
  • Price/Book 22.81
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 30.92% ( -0.70%)
  • Historical Volatility 17.69%
  • IV Percentile 98%
  • IV Rank 87.00%
  • IV High 33.07% on 04/16/24
  • IV Low 16.53% on 09/01/23
  • Put/Call Vol Ratio 0.49
  • Today's Volume 9,927
  • Volume Avg (30-Day) 11,284
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 196,822
  • Open Int (30-Day) 183,816

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 3.76
  • Number of Estimates 11
  • High Estimate 4.06
  • Low Estimate 3.32
  • Prior Year 3.98
  • Growth Rate Est. (year over year) -5.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.68 +3.16%
on 04/19/24
288.57 -6.80%
on 03/28/24
-2.80 (-1.03%)
since 03/19/24
3-Month
260.68 +3.16%
on 04/19/24
329.72 -18.44%
on 02/05/24
-38.88 (-12.63%)
since 01/19/24
52-Week
211.71 +27.03%
on 06/01/23
329.72 -18.44%
on 02/05/24
+22.72 (+9.23%)
since 04/19/23

Most Recent Stories

More News
Can This High-Yield Dividend Stock Keep Beating the S&P 500?

Amgen's shares have come under pressure this year, making it a compelling bargain buy.

AMGN : 268.93 (+2.35%)
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

Not every business in operation today is built to thrive -- or even last -- indefinitely. These are.

BRK.AX : 0.014 (unch)
BA : 169.82 (-0.24%)
DAL : 47.57 (-0.59%)
AMGN : 268.93 (+2.35%)
BRK-A : N/A (N/A)
BRK-B : N/A (N/A)
Is Amgen Stock a Buy?

Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.

AMGN : 268.93 (+2.35%)
2 Biotech Stocks to Buy Hand Over Fist in April

These drugmakers have made important moves over the past year.

AMGN : 268.93 (+2.35%)
SRPT : 115.62 (-0.80%)
3 Stocks to Consider Adding to Your Retirement Portfolio in April

Use the recent short-term weakness from these powerhouse companies' stocks to your advantage.

AMGN : 268.93 (+2.35%)
UEC : 6.79 (-0.59%)
SNOW : 145.45 (-1.99%)
Is Amgen Stock a Buy Now?

There are some worrying signs.

AMGN : 268.93 (+2.35%)
The AI Race Gets Litigious

We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.

AXON : 293.61 (-1.34%)
AAPL : 165.00 (-1.22%)
GILD : 66.76 (+0.91%)
AMGN : 268.93 (+2.35%)
EBAY : 50.39 (+0.88%)
PANW : 277.71 (-1.22%)
OKTA : 92.03 (-1.79%)
CRM : 270.37 (-0.57%)
ABBV : 166.41 (+1.06%)
Is It Time to Buy February's 3 Worst-Performing Dow Jones Stocks?

It's only a bargain price if it's actually worth owning.

CSCO : 48.32 (+0.44%)
VZ : 40.49 (+0.90%)
AMGN : 268.93 (+2.35%)
After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

The biotech tantalized investors with a very promising data update.

AMGN : 268.93 (+2.35%)
JANX : 48.69 (-0.33%)
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years

It will take a lot, but this goal isn't out of reach for these stocks.

AZN : 68.55 (+0.28%)
AMGN : 268.93 (+2.35%)
LLY : 726.31 (-2.63%)
PFE : 26.00 (+2.40%)
NVO : 122.71 (-0.03%)
VKTX : 63.42 (-1.93%)
KRYS : 158.53 (-3.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 280.68
2nd Resistance Point 275.03
1st Resistance Point 271.98
Last Price 268.93
1st Support Level 263.28
2nd Support Level 257.63
3rd Support Level 254.58

See More

52-Week High 329.72
Fibonacci 61.8% 284.64
Fibonacci 50% 270.71
Last Price 268.93
Fibonacci 38.2% 256.79
52-Week Low 211.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar